Soon after WADA took action, the FDA added BPC-157 to the so-called Category 2 Bulk Substance List, which designates it as not eligible for compounding for human use
The French vaccine company OSIVAX has employed self-assembling nanoparticles to deliver the nucleocapsid protein (NP) rather than spike/RBD for the induction of T cells and binding antibodies, both of which have been associated with protection from severe disease in humans [59, 138] (Table 2)
Words such as "believes", "expects", "anticipates", "may", "will", "should", "seeks", "approximately", "intends", "projects", "plans", "estimates" or the negative of these words or other comparable terminology (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements
reported a significant improvement in the total KOOS score (i.e., 41.89 22.89 baseline and 85.94 13.5 post-treatment, p = 0.000)